Sage Journals: Discover world-class research

Open access

Research article

First published 2024

CD8+ cell dominance in immune checkpoint inhibitor-induced colitis and its heterogeneity across endoscopic features

Min Kyu Kim, Hye-Nam Son, Seung Wook Hong [...]

Therapeutic Advances in Gastroenterology

Open access

Case report

First published 2025

Immune-related adverse events—pembrolizumab-induced colitis—the importance of early diagnosis and treatment: A case report and review of the literature

Marina Markovic, Danijela Niciforovic, Violeta Mladenovic [...]

International Journal of Immunopathology and Pharmacology

Open access

Review article

First published 2019

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

Uday N. Shivaji, Louisa Jeffery, Xianyong Gui [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2025-2

Vascular E-selectin Expression Recognized by the U12-12 Monoclonal Antibody as a Predictive Marker for Steroid Resistance in Immune Checkpoint Inhibitor-related Colitis

Koki Nakashima, Tadanobu Nagaya, Mai Iwaya [...]

Journal of Histochemistry & Cytochemistry

Retricted access

Research article

First published 2025-6

Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale

Trang L. Nguyen, Alice Tew, Laura Kirton [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021

Prevalence,therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis

Sophia H. Verspohl, Tobias Holderried, Charlotte Behning [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Case report

First published 2020-10

Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia

Ali Yılmaz, Cem Mirili, Mehmet Bilici [...]

Journal of Oncology Pharmacy Practice

Search results

CD8+ cell dominance in immune checkpoint inhibitor-induced colitis and its heterogeneity across endoscopic features

Immune-related adverse events—pembrolizumab-induced colitis—the importance of early diagnosis and treatment: A case report and review of the literature

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

Vascular E-selectin Expression Recognized by the U12-12 Monoclonal Antibody as a Predictive Marker for Steroid Resistance in Immune Checkpoint Inhibitor-related Colitis

Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale

Prevalence,therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis

Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia